Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...
These milestones are historic, yet they also compel us to confront the sad reality that over 160 years since the Civil Rights Act of 1866, and 60 years beyond the historic 1960s civil rights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback